zoledronic acid has been researched along with Leukemia, Myelomonocytic, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mori, T; Shima, H; Shimada, H; Shimasaki, N; Takahashi, T; Yoshihara, H | 1 |
| Hasegawa, D; Kawasaki, H; Manabe, A; Nakahata, T; Ohtsuka, Y; Tanizawa, T; Tsuji, K; Watanabe, S; Zaike, Y | 1 |
2 other study(ies) available for zoledronic acid and Leukemia, Myelomonocytic, Acute
| Article | Year |
|---|---|
Little response to zoledronic acid in a child of juvenile myelomonocytic leukemia (JMML) harboring the PTPN11 mutation.
Topics: Bone Density Conservation Agents; Child, Preschool; Diphosphonates; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Leukemia, Myelomonocytic, Acute; Male; Mutation; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatases; SH2 Domain-Containing Protein Tyrosine Phosphatases; src Homology Domains; Treatment Outcome; Zoledronic Acid | 2005 |
RAS-blocking bisphosphonate zoledronic acid inhibits the abnormal proliferation and differentiation of juvenile myelomonocytic leukemia cells in vitro.
Topics: Adolescent; Bone Marrow; Cell Differentiation; Cell Proliferation; Diphosphonates; Flow Cytometry; Humans; Imidazoles; Leukemia, Myelomonocytic, Acute; Leukemia, Myelomonocytic, Chronic; Phosphates; ras Proteins; Tumor Cells, Cultured; Zoledronic Acid | 2005 |